CUI · 28368143 · J231056/2011 · ILFOV

BLD PHARMA SRL

Intr. SULFINEI, Nr. 96
Măgurele, ILFOV, 77125

FalimentPJ5 cases

ANAF Live Status

Synced 13d ago
Inactiv fiscalINREGISTRAT din data 18.04.2011

Inactivat: 17 Sept 2024

VAT payerNoNe-plătitor TVA
Cash VATNo
Split VATNo
e-FacturaYesÎnrolat

Source: ANAF PlatitorTvaRest v9 (public API · no auth · daily sync). Covers VAT registration, cash-basis VAT, split-payment VAT, e-Factura enrollment, and fiscal inactivity.

Revenue · 2017

143.0M RON

+4%

Net Profit · 2017

276.8K RON

-89%

Employees · 2017

N/A

Equity · 2017

8.5M RON

+3%

Registration

Trade Register:J231056/2011
Registered:21.01.2025 14:29:31
Unit type:Sediu central

Contact

Phone:0769225374

Tax Status

Non-VATIMP100

Address

Măgurele

ILFOV

77125

Financial Health Score

56/100
Safe zoneWorsening

Altman Z″ inputs · 2017

WC / TA
0.36
RE / TA
0.10
EBIT / TA
0.00
Eq / Liab
0.11
How is this calculated?

We apply the Altman Z″, a bankruptcy-prediction score published by Edward Altman for private, non-manufacturing companies. It combines four ratios — each captures a different aspect of financial health — and weights them:

Z″ = 6.56·X1 + 3.26·X2 + 6.72·X3 + 1.05·X4
  • X1 — Working Capital / Total Assets · short-term liquidity.
  • X2 — Retained Earnings / Total Assets · cumulative profitability.
  • X3 — EBIT / Total Assets · operating efficiency.
  • X4 — Equity / Total Liabilities · solvency buffer.

Thresholds (Altman, 2000): Distress < 1.1, Grey 1.1–2.6, Safe > 2.6.

The 0–100 score is a linear mapping of clamped Z″ in the [0, 5] range — a visual shorthand, not an additional metric. Hover any year on the chart to see the per-year breakdown.

Caveats: Romanian bilanț doesn't split liabilities into short/long-term, so we approximate current liabilities as 0.7·I7 (SME heuristic). EBIT is approximated with I16 (gross profit), since interest is bundled into I15.

Z″ over time

Distress < 1.1 · Caution 1.1–2.6 · Safe > 2.6

Financial Performance

14 years of reporting

All figures sourced from ANAF and Ministerul Finanțelor filings. Click any data point to explore.

2011 — 2024

Net turnover (revenue) & Net Profit

Assets × Liabilities

Balance Sheet Overview

Revenues vs expenses

Total revenues vs Total expenses

Since 2016

Avg. number of employees

Year 2017

Asset Breakdown

Raw Data

Raw Financial Data

YearNet turnover (revenue)Net profitTotal liabilitiesFixed assetsCurrent assetsShareholders' equityAvg. number of employeesInventoriesReceivablesCash & bank accountsPrepaid expensesDeferred revenueProvisionsPaid-in share capitalState patrimonyTotal revenuesTotal expensesGross profitGross lossNet loss
2017
142.977.301
+4.2%
276.777
-88.9%
75.901.208
+5.0%
918.617
+8.9%
83.348.472
+4.6%
8.504.021
+3.4%
17.695.140
-18.1%
65.644.263
+13.1%
9.069
-48.5%
138.140
200
+0.0%
142.981.881
+4.2%
142.640.894
+6.3%
340.987
-88.9%
0
0
2016
137.230.143
2.489.742
72.267.230
-17.0%
843.847
-26.0%
79.650.627
-13.1%
8.227.244
+43.4%
67
21.593.154
+53.5%
58.039.875
-25.0%
17.598
-92.3%
200
+0.0%
137.233.893
-26.2%
134.165.052
-24.3%
3.068.841
-98.2%
0
-100.0%
0
-100.0%
2015
0
87.101.466
-9.6%
1.139.651
+17.3%
91.649.672
-5.4%
5.737.813
+272.0%
0
14.070.703
+60.8%
77.351.258
-12.1%
227.711
+157.9%
49.956
200
+0.0%
185.833.310
-23.4%
177.332.520
-26.9%
172.303.187
-28.9%
5.029.333
+1119.8%
4.195.183
+1021.8%
2014
0
96.305.133
-51.8%
971.344
+86.8%
96.876.419
-51.3%
1.542.630
+32.0%
0
8.749.077
-50.0%
88.039.045
-50.3%
88.297
-97.9%
200
+0.0%
242.721.704
-5.8%
242.721.704
-5.8%
242.309.397
-5.5%
412.307
-64.8%
373.985
-63.0%
2013
0
199.693.392
+205.0%
519.964
+616.9%
198.794.573
+203.3%
1.168.645
+635.1%
0
17.494.485
+35.2%
177.162.137
+237.0%
4.137.951
+19575.5%
1.547.500
+10356.8%
200
+0.0%
257.640.974
+90.3%
257.640.974
+90.3%
256.470.249
+90.0%
1.170.725
+218.0%
1.009.669
+194.5%
2012
0
65.465.940
72.530
65.537.587
158.976
0
12.944.493
52.572.063
21.031
14.799
200
135.358.933
135.358.933
134.990.744
368.189
342.861
BLD PHARMA SRL · CUI 28368143 | entitate